clinical trial design

Articles

Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That

If drug developers design trials to measure how well their drug addresses the issues most important to the target patient community, we could expect to end up with better drugs. Integrating patient-reported…

News

Combination immunotherapy with novel immune-oncology agents benefit NSCLC patients in presurgical setting

Patients with resectable non-small-cell lung cancer show improved major pathological response rates with combination immune oncology agents versus single-agent immunotherapy. The NeoCOAST trial, published in Cancer Discovery, 14 September, demonstrated that combining…